Understanding the clinical genetics of kidney stone disease using the Natera Renasight panel
Authors:
- Andrewe L. BacaABAndrewe L. Baca
- Rutul D. PatelRPRutul D. Patel
- Kevin LabagnaraKLKevin Labagnara
- Benjamin GreenBGBenjamin Green
- Michael ZhuMZMichael Zhu
- Kavita GuptaKGKavita Gupta
- Beth EdelbluteBEBeth Edelblute
- Andrea A. AsencioAAAndrea A. Asencio
- Deep SharmaDSDeep Sharma
- Wei ChenWCWei Chen
- Dima RaskolnikovDRDima Raskolnikov
- Jillian DonnellyJDJillian Donnelly
Open Access
- 24 March 2025
- journal article
- research article
- Published by Springer Nature in Urolithiasis
- Vol. 53 (1) , 1-7
Abstract
We aimed to characterize the underlying genetics of kidney stone disease (KSD) in an urban and diverse population using the Natera Renasight genetic panel. This was a single-center prospective study of high-risk KSD patients, defined as recurrent stone formers or those with a family history with KSD. Buccal saliva DNA samples were collected with the commercially available Natera Renasight genetic panel and were analyzed using next-generation sequencing. The panel assesses 385 kidney disease related genes, including 45 linked to KSD. One hundred eleven high-risk KSD patients were enrolled. The majority were female (56%) with a median age of 50 (IQR 39.5–59.5), compromising a diverse ethnic background with 62% Hispanic, 23% White and 11% Black. Patients had median 3 (IQR 2–5) lifetime stone episodes, and 41% had family history of KSD. Genetic analysis was possible for 105 patients (95%). Eight (8%) had positive tests with only one patient found to have a pathogenic mutation associated with KSD (SLC7A9, cystinuria). The other 7 positive tests included amyloidosis (TTR, N = 3), Alport syndrome (COL4A3, N = 2), polycystic kidney disease (PKD1, N = 1), and susceptibility to ESRD (APOL1, N = 1). Patients with positive tests were more likely to have chronic kidney disease (38% vs 5%, p < 0.01), gout (13% vs 1%, p = 0.02) and carbonate apatite stones (38% vs 7%, p < 0.01). Our study sheds light on genetic factors of KSD in a diverse patient population. The results suggest that KSD is unlikely monogenetic in nature, but is more likely due to a complex interplay of polygenetic and environmental influences. Genetic testing may be most useful in KSD patients with chronic kidney disease.Keywords
Funding Information
- Natera
This publication has 20 references indexed in Scilit:
- Common and rare variants associated with kidney stones and biochemical traitsNature Communications, 2015
- The Search for Monogenic Causes of Kidney StonesJournal of the American Society of Nephrology, 2015
- Fourteen Monogenic Genes Account for 15% of Nephrolithiasis/NephrocalcinosisJournal of the American Society of Nephrology, 2015
- Medical Management of Kidney Stones: AUA GuidelineJournal of Urology, 2014
- Primary HyperoxaluriaNew England Journal of Medicine, 2013
- Human SLC26A1 Gene Variants: A Pilot StudyThe Scientific World Journal, 2013
- Mutations Associated with Functional Disorder of Xanthine Oxidoreductase and Hereditary Xanthinuria in HumansInternational Journal of Molecular Sciences, 2012
- Genetic causes of hypercalciuric nephrolithiasisPediatric Nephrology, 2008
- A twin study of genetic and dietary influences on nephrolithiasis: A report from the Vietnam Era Twin (VET) RegistryKidney International, 2005
- Molecular identification of a renal urate–anion exchanger that regulates blood urate levelsNature, 2002